1. Home
  2. ARCT vs HBCP Comparison

ARCT vs HBCP Comparison

Compare ARCT & HBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • HBCP
  • Stock Information
  • Founded
  • ARCT 2013
  • HBCP 1908
  • Country
  • ARCT United States
  • HBCP United States
  • Employees
  • ARCT N/A
  • HBCP N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • HBCP Banks
  • Sector
  • ARCT Health Care
  • HBCP Finance
  • Exchange
  • ARCT Nasdaq
  • HBCP Nasdaq
  • Market Cap
  • ARCT 526.5M
  • HBCP 421.4M
  • IPO Year
  • ARCT N/A
  • HBCP 2008
  • Fundamental
  • Price
  • ARCT $7.34
  • HBCP $54.39
  • Analyst Decision
  • ARCT Buy
  • HBCP Buy
  • Analyst Count
  • ARCT 11
  • HBCP 2
  • Target Price
  • ARCT $38.67
  • HBCP $63.50
  • AVG Volume (30 Days)
  • ARCT 2.2M
  • HBCP 25.3K
  • Earning Date
  • ARCT 11-10-2025
  • HBCP 10-20-2025
  • Dividend Yield
  • ARCT N/A
  • HBCP 2.28%
  • EPS Growth
  • ARCT N/A
  • HBCP 24.56
  • EPS
  • ARCT N/A
  • HBCP 5.62
  • Revenue
  • ARCT $97,601,000.00
  • HBCP $145,087,000.00
  • Revenue This Year
  • ARCT N/A
  • HBCP $2.60
  • Revenue Next Year
  • ARCT $26.81
  • HBCP $3.27
  • P/E Ratio
  • ARCT N/A
  • HBCP $9.70
  • Revenue Growth
  • ARCT N/A
  • HBCP 11.42
  • 52 Week Low
  • ARCT $7.26
  • HBCP $39.59
  • 52 Week High
  • ARCT $24.17
  • HBCP $61.07
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 26.87
  • HBCP 51.28
  • Support Level
  • ARCT $7.93
  • HBCP $53.14
  • Resistance Level
  • ARCT $9.29
  • HBCP $55.55
  • Average True Range (ATR)
  • ARCT 0.57
  • HBCP 1.07
  • MACD
  • ARCT -0.03
  • HBCP 0.14
  • Stochastic Oscillator
  • ARCT 0.31
  • HBCP 58.86

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About HBCP Home Bancorp Inc.

Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.

Share on Social Networks: